Target intelligence / Profile preview

Snake venom protein

Molecular classification
Enzyme (e.g., phospholipase A2, L-amino acid oxidase, hyaluronidase), Peptide toxin (e.g., three-finger toxin, Kunitz peptide, disintegrin), Metalloprotease (e.g., snake venom metalloprotease), Lectin (e.g., C-type lectin/snaclec), Proteinase (e.g., serine protease), Other
01

Overview

Snake venom proteins" is a generic term for the **diverse set of enzymatic and non-enzymatic proteins and peptides** found in the venom of snakes belonging to multiple families (notably Elapidae, Viperidae, and others)[1][2][3]. These proteins include several major families such as **phospholipase A2, metalloproteases, serine proteases, and three-finger toxins**, among others, each responsible for specific biological effects like neurotoxicity, cytotoxicity, hemotoxicity, and prey immobilization[1][2][3]. Each snake species expresses a distinct cocktail of these proteins, with the relative abundance and presence of specific families varying across taxonomic groups[1][2]. While these proteins are **the direct cause of symptoms seen in snakebite envenomation**, including bleeding, tissue necrosis, coagulation disorders, paralysis, and death, they also represent a toolbox for drug discovery and pathophysiological research[1][2][3]. **Important note:** "Snake venom proteins" is not a single, well-defined molecule or target, but a heterogeneous mix of biomolecules, each with distinct modes of action and potential as individual drug targets or toxins. Therefore, this entry is **too broad for typical structured molecular target curation and is not itself a therapeutic target, but rather a category or mixture**[1]. **Correction:** For structured data curation, focus on individual protein families or specific toxins (e.g., "Snake venom phospholipase A2," "Three-finger toxin," or "Snake venom metalloprotease"), not on the category "snake venom proteins" as a whole.

Other names
Snake venom componentsSnake venom toxinsSnake venom proteome
02

Mechanism of action

Block neuromuscular transmission (three-finger toxins and β-bungarotoxins); Hydrolyze phospholipids in cell membranes (phospholipase A2); Proteolytic cleavage of clotting factors and extracellular matrix (metalloproteases, serine proteases); Inhibit platelet aggregation or promote thrombosis (C-type lectins, disintegrins); Cause direct cell lysis (L-amino acid oxidase, others)

03

Biological functions

CytotoxicityNeurotoxicity (e.g., block neurotransmission)Hemotoxicity (e.g., disrupt blood coagulation, vascular damage)Myotoxicity (damage muscle tissue)Modulation of hemostasis (blood clotting and platelet aggregation)Modulation of cell signalingImmune modulationPrey immobilization and digestion
04

Disease associations

Envenomation (systemic toxicity in snakebite victims)Cardiovascular damageCoagulopathy/bleeding disordersAcute renal failureLocal tissue necrosisNeuroparalysisInflammationInfection (secondary consequence of tissue damage)
05

Safety considerations

Antivenom hypersensitivity (allergic and serum sickness reactions)Rapid tissue destruction/necrosisIncomplete neutralization with current antivenoms (species and component selection)Systemic effects difficult to predict due to venom variability
06

Interacting drugs

Antivenoms (immunoglobulin-based, polyclonal or monoclonal)

3 more in the full profile.

07

Biomarkers

Circulating venom antigen (for identifying snake envenomation)Specific enzyme activity in blood (e.g., increased PLA2, metalloprotease activity)Coagulation panel abnormalities (D-dimer, fibrinogen degradation, etc.)

Beyond the preview

Go deeper on Snake venom protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Snake venom protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call